Earnings (Loss) Per Share - Schedule of Common Equivalent Shares Outstanding at Period-End Have Been Excluded from Computation of Earnings Per Share, as their Inclusion Would Have Been Anti-Dilutive (Details) - shares	3 Months Ended		9 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Options to Purchase Common Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive shares excluded from calculation of computation of earnings per share	400	927	400	927
Stock Appreciation Rights (SARs)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive shares excluded from calculation of computation of earnings per share	770,969	797,110	770,969	762,239
Warrants to Purchase Common Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive shares excluded from calculation of computation of earnings per share	2,656,667	2,666,667	2,656,667	2,666,667